Skip to main content
Erschienen in: Digestive Diseases and Sciences 2/2011

01.02.2011 | Original Article

Hemodynamic Assessment of the Development of Portal-Systemic Collaterals in Portal Hypertensive Rats

verfasst von: Che-Chang Chan, Shiow-Chwen Tsai, Ling-Yi Cheng, Fa-Yauh Lee, Han-Chieh Lin

Erschienen in: Digestive Diseases and Sciences | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Portal hypertension induced the formation of portal-systemic collaterals. Revealing the developmental change of portal-systemic collaterals is important for future therapy.

Methods

We observed the evolution of an accessible shunting vessel, the spleno-renal shunt (SRS), in rats after induction of portal hypertension by partial portal vein ligation (PVL). The hemodynamic and histological assessments of SRS were performed by transit time ultrasound and immunohistochemical studies.

Results

The portal pressure of PVL rats surged to 16.5 ± 1.1 mmHg on day 1 after ligation surgery and was maintained at a significantly higher level (13.0 ± 0.4 mmHg) to day 14 when compared to sham rats (p < 0.05). The size or flow of SRS in PVL rats did not change immediately after portal pressure surge. Instead, they increased rapidly on day 4, peaked on day 7, and stabilized thereafter. The size and flow were greater and the resistance of SRS was lower in PVL rats after day 7 (p < 0.05). The anti-Ki67 immunohistochemical study demonstrated positive staining of endothelium in SRS and negative in portal vein or aorta of PVL rats. In addition, the endothelial cells of SRS were stained positive for CD31 and KLF5.

Conclusions

We concluded that the pressure-induced opening of pre-existing vessels was not the primary underlying mechanism in the formation of SRS. Endothelial proliferating and vascular remodeling process participated actively during the development of SRS. These observations can be used for studying the pathogenesis and developing more effective anti-portal hypertensive therapy in the future.
Literatur
1.
Zurück zum Zitat Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol. 1983;244:G52–G57.PubMed Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol. 1983;244:G52–G57.PubMed
2.
Zurück zum Zitat Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol. 1985;248:G618–G625.PubMed Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol. 1985;248:G618–G625.PubMed
3.
Zurück zum Zitat Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology. 1985;5:419–424.CrossRefPubMed Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology. 1985;5:419–424.CrossRefPubMed
4.
5.
Zurück zum Zitat Chan CC, Lee FY, Wang SS, Chang FY, et al. Effects of vasopressin on portal-systemic collaterals in portal hypertensive rats: role of nitric oxide and prostaglandin. Hepatology. 1999;30:630–635.CrossRefPubMed Chan CC, Lee FY, Wang SS, Chang FY, et al. Effects of vasopressin on portal-systemic collaterals in portal hypertensive rats: role of nitric oxide and prostaglandin. Hepatology. 1999;30:630–635.CrossRefPubMed
6.
Zurück zum Zitat Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology. 2008;134:1715–1728.CrossRefPubMed Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology. 2008;134:1715–1728.CrossRefPubMed
7.
Zurück zum Zitat Fernandez M, Vizzutti F, Garcia-Pagan JC, Rodes J, Bosch J. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. Gastroenterology. 2004;126:886–894.CrossRefPubMed Fernandez M, Vizzutti F, Garcia-Pagan JC, Rodes J, Bosch J. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. Gastroenterology. 2004;126:886–894.CrossRefPubMed
8.
Zurück zum Zitat Sass DA, Chopra KB. Portal hypertension and variceal hemorrhage. Med Clin North Am. 2009;93:837–853. vii–viii.CrossRefPubMed Sass DA, Chopra KB. Portal hypertension and variceal hemorrhage. Med Clin North Am. 2009;93:837–853. vii–viii.CrossRefPubMed
9.
Zurück zum Zitat Kroeger RJ, Groszmann RJ. Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model. Hepatology. 1985;5:97–101.CrossRefPubMed Kroeger RJ, Groszmann RJ. Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model. Hepatology. 1985;5:97–101.CrossRefPubMed
10.
Zurück zum Zitat Kravetz D, Sikuler E, Groszmann RJ. Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution. Gastroenterology. 1986;90:1232–1240.PubMed Kravetz D, Sikuler E, Groszmann RJ. Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution. Gastroenterology. 1986;90:1232–1240.PubMed
11.
Zurück zum Zitat Halvorsen JF, Myking AO. The porto-systemic collateral pattern in the rat. An angiographic and anatomical study after partial occlusion of the portal vein. Eur Surg Res. 1974;6:183–195.CrossRefPubMed Halvorsen JF, Myking AO. The porto-systemic collateral pattern in the rat. An angiographic and anatomical study after partial occlusion of the portal vein. Eur Surg Res. 1974;6:183–195.CrossRefPubMed
12.
Zurück zum Zitat Tanoue K, Kitano S, Hashizume M, Wada H, Sugimachi K. A rat model of esophageal varices. Hepatology. 1991;13:353–358.CrossRefPubMed Tanoue K, Kitano S, Hashizume M, Wada H, Sugimachi K. A rat model of esophageal varices. Hepatology. 1991;13:353–358.CrossRefPubMed
13.
Zurück zum Zitat Sugiura N, Karasawa E, Saotome N, Miki M, et al. Portosystemic collateral shunts originating from the left portal veins in portal hypertension: demonstration by color Doppler flow imaging. J Clin Ultrasound. 1992;20:427–432.CrossRefPubMed Sugiura N, Karasawa E, Saotome N, Miki M, et al. Portosystemic collateral shunts originating from the left portal veins in portal hypertension: demonstration by color Doppler flow imaging. J Clin Ultrasound. 1992;20:427–432.CrossRefPubMed
14.
Zurück zum Zitat Cales P, Oberti F, Veal N, Fort J, et al. Spleno-renal shunt blood flow by transit-time ultrasound as an index of collateral circulation in portal hypertensive rats. Hepatology. 1998;28:1269–1274.CrossRefPubMed Cales P, Oberti F, Veal N, Fort J, et al. Spleno-renal shunt blood flow by transit-time ultrasound as an index of collateral circulation in portal hypertensive rats. Hepatology. 1998;28:1269–1274.CrossRefPubMed
15.
Zurück zum Zitat Veal N, Oberti F, Moal F, Vuillemin E, et al. Spleno-renal shunt blood flow is an accurate index of collateral circulation in different models of portal hypertension and after pharmacological changes in rats. J Hepatol. 2000;32:434–440.CrossRefPubMed Veal N, Oberti F, Moal F, Vuillemin E, et al. Spleno-renal shunt blood flow is an accurate index of collateral circulation in different models of portal hypertension and after pharmacological changes in rats. J Hepatol. 2000;32:434–440.CrossRefPubMed
16.
Zurück zum Zitat Aydin U, Yazici P, Kilic M. Porto-systemic shunt using adrenal vein as a conduit; an alternative procedure for spleno–renal shunt. BMC Surg. 2007;7:7.CrossRefPubMed Aydin U, Yazici P, Kilic M. Porto-systemic shunt using adrenal vein as a conduit; an alternative procedure for spleno–renal shunt. BMC Surg. 2007;7:7.CrossRefPubMed
17.
Zurück zum Zitat Chojkier M, Groszmann RJ. Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres. Am J Physiol. 1981;240:G371–G375.PubMed Chojkier M, Groszmann RJ. Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres. Am J Physiol. 1981;240:G371–G375.PubMed
18.
Zurück zum Zitat D’Almeida MS, Cailmail S, Lebrec D. Validation of transit-time ultrasound flow probes to directly measure portal blood flow in conscious rats. Am J Physiol. 1996;271:H2701–H2709.PubMed D’Almeida MS, Cailmail S, Lebrec D. Validation of transit-time ultrasound flow probes to directly measure portal blood flow in conscious rats. Am J Physiol. 1996;271:H2701–H2709.PubMed
19.
Zurück zum Zitat D’Almeida MS, Gaudin C, Lebrec D. Validation of 1- and 2-mm transit-time ultrasound flow probes on mesenteric artery and aorta of rats. Am J Physiol. 1995;268:H1368–H1372.PubMed D’Almeida MS, Gaudin C, Lebrec D. Validation of 1- and 2-mm transit-time ultrasound flow probes on mesenteric artery and aorta of rats. Am J Physiol. 1995;268:H1368–H1372.PubMed
20.
Zurück zum Zitat Groszmann RJ, Vorobioff J, Riley E. Splanchnic hemodynamics in portal-hypertensive rats: measurement with gamma-labeled microspheres. Am J Physiol. 1982;242:G156–G160.PubMed Groszmann RJ, Vorobioff J, Riley E. Splanchnic hemodynamics in portal-hypertensive rats: measurement with gamma-labeled microspheres. Am J Physiol. 1982;242:G156–G160.PubMed
21.
Zurück zum Zitat Pizcueta MP, de Lacy AM, Kravetz D, Bosch J, Rodes J. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats. Hepatology. 1989;10:953–957.CrossRefPubMed Pizcueta MP, de Lacy AM, Kravetz D, Bosch J, Rodes J. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats. Hepatology. 1989;10:953–957.CrossRefPubMed
22.
Zurück zum Zitat Myers SI, Hernandez R, Castaneda A. Oxygen free radicals regulate splanchnic nitric oxide synthesis and blood flow. Cardiovasc Surg. 1995;3:207–210.CrossRefPubMed Myers SI, Hernandez R, Castaneda A. Oxygen free radicals regulate splanchnic nitric oxide synthesis and blood flow. Cardiovasc Surg. 1995;3:207–210.CrossRefPubMed
23.
Zurück zum Zitat Van Orden DE, Farley DB, Fastenow C, Brody MJ. A technique for monitoring blood flow changes with miniaturized Doppler flow probes. Am J Physiol. 1984;247:H1005–H1009.PubMed Van Orden DE, Farley DB, Fastenow C, Brody MJ. A technique for monitoring blood flow changes with miniaturized Doppler flow probes. Am J Physiol. 1984;247:H1005–H1009.PubMed
24.
Zurück zum Zitat Unthank JL, Nixon JC, Dalsing MC. Acute compensation to abrupt occlusion of rat femoral artery is prevented by NO synthase inhibitors. Am J Physiol. 1994;267:H2523–H2530.PubMed Unthank JL, Nixon JC, Dalsing MC. Acute compensation to abrupt occlusion of rat femoral artery is prevented by NO synthase inhibitors. Am J Physiol. 1994;267:H2523–H2530.PubMed
25.
Zurück zum Zitat Schima H, Huber L, Schmallegger H, Drost CJ, et al. Flow measurement at the pump head of centrifugal pumps: comparison of ultrasonic transit time and ultrasonic Doppler systems. Artif Organs. 1997;21:808–815.CrossRefPubMed Schima H, Huber L, Schmallegger H, Drost CJ, et al. Flow measurement at the pump head of centrifugal pumps: comparison of ultrasonic transit time and ultrasonic Doppler systems. Artif Organs. 1997;21:808–815.CrossRefPubMed
26.
Zurück zum Zitat Nagai R, Suzuki T, Aizawa K, Shindo T, Manabe I. Significance of the transcription factor KLF5 in cardiovascular remodeling. J Thromb Haemost. 2005;3:1569–1576.CrossRefPubMed Nagai R, Suzuki T, Aizawa K, Shindo T, Manabe I. Significance of the transcription factor KLF5 in cardiovascular remodeling. J Thromb Haemost. 2005;3:1569–1576.CrossRefPubMed
27.
Zurück zum Zitat Moreau R. VEGF-induced angiogenesis drives collateral circulation in portal hypertension. J Hepatol. 2005;43:6–8.CrossRefPubMed Moreau R. VEGF-induced angiogenesis drives collateral circulation in portal hypertension. J Hepatol. 2005;43:6–8.CrossRefPubMed
28.
Zurück zum Zitat Fernandez M, Mejias M, Angermayr B, Garcia-Pagan JC, et al. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. J Hepatol. 2005;43:98–103.CrossRefPubMed Fernandez M, Mejias M, Angermayr B, Garcia-Pagan JC, et al. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. J Hepatol. 2005;43:98–103.CrossRefPubMed
29.
Zurück zum Zitat Fernandez M, Mejias M, Garcia-Pras E, Mendez R, et al. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Hepatology. 2007;46:1208–1217.CrossRefPubMed Fernandez M, Mejias M, Garcia-Pras E, Mendez R, et al. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Hepatology. 2007;46:1208–1217.CrossRefPubMed
30.
Zurück zum Zitat Tiani C, Garcia-Pras E, Mejias M, de Gottardi A, et al. Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension. J Hepatol. 2009;50:296–305.CrossRefPubMed Tiani C, Garcia-Pras E, Mejias M, de Gottardi A, et al. Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension. J Hepatol. 2009;50:296–305.CrossRefPubMed
31.
Zurück zum Zitat Chang CC, Huang HC, Wang SS, Lee FY, et al. Involvement of constitutive nitric oxide synthase in the portal-systemic collaterals of portal hypertensive rats. J Chin Med Assoc. 2005;68:245–249.CrossRefPubMed Chang CC, Huang HC, Wang SS, Lee FY, et al. Involvement of constitutive nitric oxide synthase in the portal-systemic collaterals of portal hypertensive rats. J Chin Med Assoc. 2005;68:245–249.CrossRefPubMed
Metadaten
Titel
Hemodynamic Assessment of the Development of Portal-Systemic Collaterals in Portal Hypertensive Rats
verfasst von
Che-Chang Chan
Shiow-Chwen Tsai
Ling-Yi Cheng
Fa-Yauh Lee
Han-Chieh Lin
Publikationsdatum
01.02.2011
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 2/2011
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1302-6

Weitere Artikel der Ausgabe 2/2011

Digestive Diseases and Sciences 2/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.